Author:
Chauhan Dharminder,Catley Laurence,Li Guilan,Podar Klaus,Hideshima Teru,Velankar Mugdha,Mitsiades Constantine,Mitsiades Nicolas,Yasui Hiroshi,Letai Anthony,Ovaa Huib,Berkers Celia,Nicholson Benjamin,Chao Ta-Hsiang,Neuteboom Saskia T.C.,Richardson Paul,Palladino Michael A.,Anderson Kenneth C.
Subject
Cancer Research,Cell Biology,Oncology
Reference39 articles.
1. Preclinical and clinical evaluation of proteasome inhibitor PS-341 for the treatment of cancer;Adams;Curr. Opin. Chem. Biol.,2002
2. The proteasome: a suitable antineoplastic target;Adams;Nat. Rev. Cancer,2004
3. Proteasome inhibitors: a novel class of potent and effective antitumor agents;Adams;Cancer Res.,1999
4. Bortezomib therapy for myeloma;Anderson;Curr. Hematol. Rep.,2004
5. Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib;Berkers;Nat. Methods,2005
Cited by
631 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献